September 2024 FDA Recall Drug by Glenmark Pharmaceuticals Inc., Usa
D-0002-2025 - Defective Container

This Class III drug recall was voluntarily initiated by Glenmark Pharmaceuticals Inc., Usa on September 30, 2024 for the product Drug. The FDA reported the reason for recall as defective container. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0002-2025

Reason for Recall
Defective Container: Firm received complaints of broken tube at the seal.
Initiated
09-30-2024
Reported
10-09-2024
Quantity
11,568 tubes

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Glenmark Pharmaceuticals Inc., USA
Nationwide in the US.
Ciclopirox Gel 0.77%, For Dermatologic Use Only, Not for Use in Eyes, Rx Only, a) 30 gm Tube, NDC 68462-0455-35; b) 45 gm Tube, NDC 68462-0455-47; c) 100 gm Tube, NDC 68462-0455-94, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.

Batch or Lot Expiration Information

Lot# s: a) 19242028, Exp. 04/30/2026; b) 19242028, Exp. 04/30/2026; c) 19242028, Exp. 04/30/2026